Please assess the completion status of the following clinical trial:

Trial Title: Correlation of FeNO, Blood Eosinophils, Bronchoalveolar Lavage Findings and Bronchial Epithelium Histopathology in Patients With Chronic Obstructive Pulmonary Disease and Asthma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with diagnosis of COPD or asthma (according to the guidelines)~* Age \>18 years~* Indication for bronchoscopy for medical reasons (not study-related)~* Ability to provide informed consent~Exclusion Criteria:~* paO2 \<60 mmHg on 4L 02 /min, paCO2 \> 55 mmHg on room air~* FEV1 \<20%~* Pulmonary infection or exacerbation within the last 4 weeks~* Additional pulmonary diseases (pneumonia, lung cancer, tuberculosis, interstitial lung disease)~* Contraindication for BAL, PSB sampling or endobronchial biopsy~* Current use of anticoagulants that can not be stopped for bronchoscopy~* Heart failure with left ventricular ejection fraction \<30%~* Myocardial infarction in previous 6 months~* Significant pulmonary hypertension (PAPS \>45 mmHg, right heart failure \[echocardiography\] and/or PAPm \>35 mmHg \[right heart catheter\])

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with COPD (Type: None): The following parameters are to be evaluated:~* Blood eosinophils~* FeNO~* Eosinophils in bronchoalveolar lavage~* Tissue eosinophilia (protected specimen brush sampling, endobronchial biopsy)
- Patients with asthma (Type: None): The following parameters are to be evaluated:~* Blood eosinophils~* FeNO~* Eosinophils in bronchoalveolar lavage~* Tissue eosinophilia (protected specimen brush sampling, endobronchial biopsy)

Based on this trial design, predict the completion outcome and termination type (if applicable).